PRO-087: Clinical Trials

3 trials of PRO-087, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 2 Phase 4, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 42Completed 2
Phase 11Completed 1

Follow PRO-087: new trials by email Literature Review of PRO-087 trials Research Report on PRO-087

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study to Compare the Efficacy of the Ophthalmic Solution Humylub Ofteno® PF With Hyabak® and Lagricel Ofteno® PF as Treatment for Dry Eye.
Sodium hyaluronate 0.1%/chondroitin sulfate 0.18%, Sodium hyaluronate 0.15%, Sodium hyaluronate 0.4% - Dry Eye
Phase 4CompletedLaboratorios Sophia S.A de C.V.1822021-12-092026-02-20
Safety and Tolerability of PRO-087 Versus Xyel Ofteno® and Systane Ultra®, on the Ocular Surface of Healthy Subjects
PRO-087, Systane Ultra, Xyel Ofteno - Dry Eye Syndromes, Lubricant Allergy
Phase 1CompletedLaboratorios Sophia S.A de C.V.302017-07-172019-07-19
Efficacy and Safety of the Ophthalmic Solution PRO-087 Versus Systane ® Ultra and Ultra Preservative Free (087LATAMFIV)
PRO-087, Systane Ultra, Systane Ultra Preservative Free - Dry Eye Syndrome
Phase 4CompletedLaboratorios Sophia S.A de C.V.3262016-10-132019-10-31

Conditions studied

Dry Eye Syndromes (3)

Sponsors

Laboratorios Sophia S.A de C.V. (3)

Countries

Mexico (3)

Top investigators

Leopoldo Baiza, MD (1)

Results publications

PMID 34707360, PMID 39233999